Showing 1391-1400 of 1635 results for "".
- Study Finds Recycling of the Eye’s Light Sensors Is Faulty in Progressive Blindness of Older Adultshttps://modernod.com/news/study-finds-recycling-of-the-eyes-light-sensors-is-faulty-in-progressive-blindness-of-older-adults/2479323/With the National Eye Institute reporting that about 11 million older adults in the US endure age-related macular degeneration (AMD), University of Maryland School of Medicine (UMSOM) researchers are starting to understand what goes wrong in the disease, in order to develop new therapies to tre
- Oyster Point Announces Enrollment of First Subject in the OLYMPIA Phase 2 Clinical Trial for Patients with Neurotrophic Keratopathyhttps://modernod.com/news/oyster-point-announces-enrollment-of-first-subject-in-the-olympia-phase-2-clinical-trial-for-patients-with-neurotrophic-keratopathy/2479308/Oyster Point Pharma announced enrollment of the first subject in the OLYMPIA phase 2 clinical trial of OC-01 (varenicline) nasal spray for the treatment of Stage 1 Neurotrophic Keratopathy (NK). “This is an exciting milestone as we continue to develop this potentially new tr
- Scientists Unravel the Function of a Sight-Saving Growth Factorhttps://modernod.com/news/scientists-unravel-the-function-of-a-sight-saving-growth-ffactor/2479302/Researchers at the National Eye Institute (NEI) have determined how certain short protein fragments, called peptides, can protect neuronal cells found in the light-sensing retina layer at the back of the eye. The peptides might someday be used to treat degenerative retinal diseases, such as age-r
- Avellino Launches AvaGen as First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophieshttps://modernod.com/news/avellino-launches-avagen-as-first-genetic-test-to-quantify-keratoconus-risk-and-presence-of-corneal-dystrophies/2479255/Avellino Lab USA announced full nationwide availability in the US of AvaGen, as the first genetic test that helps determine a patient’s risk of keratoconus and the presence of other corneal dystrophies. The test allows for more confident management and treatment for patients with these conditions
- GenSight Biologics Announces Case Report Showing Visual Recovery after GS030 Optogenetic Treatmenthttps://modernod.com/news/gensight-biologics-announces-nature-medicine-case-report-showing-visual-recovery-after-gs030-optogenetic-treatment/2479243/GenSight Biologics announced that the journal Nature Medicine has published the first case report of partial recovery of visual function in a blind patient with late-stage retinitis pigmentosa (RP). The subject is a participant in the ongoing PIONEER phase 1/2 clinical trial of GenSight
- Alcon Data Highlights Benefits of Specific AcrySof Modelshttps://modernod.com/news/alcon-data-highlights-benefits-of-specific-acrysof-models/2479232/Alcon has announced the publication of the National Ophthalmology Database (NOD) audit by The Royal College of Ophthalmologists (RCOphth), which collects data on cataract surgery performed in England, Wales and Guerns
- First Pediatric Patient with Rare Genetic Eye Disease Dosed in Clinical Trialhttps://modernod.com/news/first-pediatric-patient-with-rare-genetic-eye-disease-dosed-in-clinical-trial/2479207/ProQR Therapeutics has announced the first pediatric clinical trial participant has been treated in its new clinical trial named Brighten of the experimental RNA therapy sepofarsen. Brighten is a clinical study for children under 8 years old with Leber congenital amaurosis (LCA) d
- NUST MISIS Scientists Say They Developed a Safe Drug to Treat Eye Inflammationhttps://modernod.com/news/nust-misis-scientists-say-they-developed-a-safe-drug-to-treat-eye-inflammation/2479203/A Russian-American research team from The National University of Science and Technology MISIS has presented a new therapeutic method using nanoparticles of an antioxidant enzyme, developed specifically for the eyes. It relieves inflammation and repairs tissue without causing side effects: irritat
- Heine OMEGA 600 Indirect Ophthalmoscope Launched In the UKhttps://modernod.com/news/heine-omega-600-indirect-ophthalmoscope-launched-in-the-uk/2479195/John Weiss & Son has announced the launch of the Heine Omega 600 Indirect Ophthalmoscope in the UK. The new OMEGA 600 enables the clinician to provide a more accurate diagnosis. It features superior non-reflective glass optics, sharp images and reliable, natural colors. Stereoscopic ad
- Rayner’s RayOne Aspheric preloaded IOL launches in Chinahttps://modernod.com/news/rayners-rayone-aspheric-preloaded-iol-launches-in-china/2479183/Rayner announced that its RayOne Aspheric fully preloaded IOL injection system has been approved by the Chinese regulator, National Medical Products Administration (NMPA), and is now available for commercial use in China. The NMPA granted regulatory approval and sale of the 6.0 mm RayOne A